Intellectual Property Protection

Protecting our value through IP

Making an impact on the bottom line and people’s lives

AMADIX recognizes the importance of developing IP strategies early to determine how it could serve our long-term business interests. We capture the value of our innovation through strong patent protection.

Intellectual Property

Our Products

Innovation is revolutionizing cancer diagnosis.

AMADIX Test de cáncer de colon

PreveCol®

PreveCol® is an innovative blood-based test for the early detection of colorectal cancer (CRC) or advanced adenomas (AA) and precancerous lesions. Based on an algorithm that combines clinical characteristics with an analysis of biomarkers present in the individual’s blood.

CE Marked

AMADIX Test de cáncer de pulmón

DiagnoLung®

DiagnoLung® is an innovative blood-based test for the early detection of lung cancer. Non-invasive test that can be used for the diagnosis of lung cancer and as a screening tool in high-risk populations.

Under development

AMADIX Test de cáncer de páncreas

PancreaDix®

PancreaDix® is an innovative blood-based test for the detection of pancreatic cancer (ductal adenocarcinoma and preneoplastic lesions). Non-invasive test.


Under development

All our products have solid worldwide patent protection

mapa mundial de patentes de AMADIX

AMADIX’s intellectual property

If you want to learn more, please contact us.

Open chat
Hello 👋
How can we assist you today?